Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on July 25, 2017, to announce its financial results for the quarter ended June 30, 2017. The press release, attached as Exhibit 99.1, provides key performance indicators and financial condition updates for the period. Investors should review this filing for insights into the company's operational performance and financial health during the second quarter of 2017. While the 8-K itself is a notification of the press release, the press release contains the detailed financial information. Investors are encouraged to access the referenced Exhibit 99.1 to understand the specifics of revenue, profitability, and any other material updates disclosed by Quest Diagnostics for the reported quarter. This information is crucial for assessing the company's ongoing business trends and making informed investment decisions.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on July 25, 2017, announcing Q2 2017 results.
- 2The filing incorporates by reference a press release dated July 25, 2017.
- 3This press release details the company's financial results for the quarter ended June 30, 2017.
- 4Investors can find specific financial performance data within the referenced press release (Exhibit 99.1).
- 5The 8-K serves as official notification of the company's quarterly financial performance announcement.